Conversely, none of the patients with mutations directly linked to GABAergic transmission (e.g., SLC6A1, GABRA3, GABRG3) responded to CBD, suggesting that genetic disruptions in GABAergic signaling might negatively impact CBD effectiveness. This evidence concerns the gene GABRG3 and red-green color blindness.